| # | Drug | Count |
|---|---|---|
| 0 | SITAGLIPTIN | 531 |
| 1 | PACLITAXEL | 334 |
| 2 | EXENATIDE | 330 |
| 3 | GEMCITABINE HYDROCHLORIDE | 300 |
| 4 | LIRAGLUTIDE | 283 |
| 5 | GEMCITABINE | 270 |
| 6 | METFORMIN | 249 |
| 7 | METFORMIN ER 500 MG | 249 |
| 8 | METFORMIN ER 750 MG | 249 |
| 9 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 212 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 212 | 0.0098 |
| 1 | ETHIODIZED OIL | 12 | 0.0092 |
| 2 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | 11 | 0.0087 |
| 3 | SITAGLIPTIN | 531 | 0.0073 |
| 4 | EXENATIDE | 330 | 0.0063 |
| 5 | LIRAGLUTIDE | 283 | 0.0057 |
| 6 | GEMCITABINE HYDROCHLORIDE | 300 | 0.0055 |
| 7 | PANCRELIPASE | 207 | 0.0052 |
| 8 | ERLOTINIB HYDROCHLORIDE | 44 | 0.0035 |
| 9 | PACLITAXEL | 334 | 0.0033 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 647 |
| 1 | Microtubule Inhibitor [EPC] | 341 |
| 2 | Insulin Analog [EPC] | 303 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 279 |
| 4 | Corticosteroid [EPC] | 204 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 182 |
| 6 | Proton Pump Inhibitor [EPC] | 176 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 161 |
| 8 | Benzodiazepine [EPC] | 159 |
| 9 | Sulfonylurea [EPC] | 158 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cannabinoid [EPC] | 18 | 0.0022 |
| 1 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 2 | Microtubule Inhibitor [EPC] | 341 | 0.0021 |
| 3 | Antihypoglycemic Agent [EPC] | 7 | 0.0016 |
| 4 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 5 | GLP-1 Receptor Agonist [EPC] | 647 | 0.0014 |
| 6 | Sulfonylurea [EPC] | 158 | 0.0013 |
| 7 | Glinide [EPC] | 11 | 0.0012 |
| 8 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 2 | 0.0012 |
| 9 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |